ArticleMemorias do Instituto Oswaldo Cruz2020

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach.

Ísis Venturi Biembengut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.